TUC backs the FDA’s call for flexible working
The FDA’s call for the government to promote flexible working at every level across the public sector has been backed by the TUC.
Delegates at this year’s TUC Congress voted in favour of the FDA’s motion, which called on the government and employers to not only introduce a ‘day one’ right to flexible working, but to also:
- Advertise how roles can be worked flexibly, with explicit examples provided in job descriptions;
- Separate out remote working policies from flexible working provisions;
- Promote flexible working at senior levels, encouraging a more inclusive workplace; and
- Promote flexible working within public services and encourage private sector employers to offer it to all workers as a positive workforce measure.
Moving the motion, FDA President Fiona Eadie told delegates that FDA members “don’t need to be chained to a desk to do their jobs” but face barriers to flexible working because “there’s still a misconception that if they’re not visible in the office they can’t possibly be delivering”.
“We know that flexible working not only allows parents to pick up their children from school, but also allows carers to attend hospital appointments and others to proactively manage their mental health,” she explained. “It means people with disabilities can work from home when they need to. In short, flexible working allows people to balance their work around their life, without a detriment to either… The 9-5 doesn’t work for everyone – and isn’t even necessary. People should be recruited on their merit, not just their time-sheet.”
The motion follows research, commissioned by the FDA in partnership with the Global Institute for Women’s Leadership (GIWL), to find out what flexible working really looks like today. It found that nearly 50% of respondents felt that working part-time means their work is more likely to spill over in to other areas of their life, while 30% of respondents who felt that flexible working was not encouraged at their grade were working an additional 10 or more hours a week.
Additionally, 35% of part-time women thought that working flexibly had a negative impact on their career progression or performance ratings.
The full research will be launched at an FDA Centenary Lecture on 26 September, delivered by Julia Gillard, Chair of the GIWL and former Prime Minister of Australia.
Eadie also spoke in support of Unison's motion on smashing the gender pay gap, which was also carried by TUC Congress.
"The gender pay gap is a scandal," the President said. "It is especially shameful that if you are a BME woman, an LGBT+ woman or a disabled woman, the pay gap you face is even more significant than that of your white, cisgender and heterosexual or able bodied peers.
"The FDA wants employers to report pay gaps for black and ethnic minority workers, LGBT+ workers and disabled workers," Eadie continued, "and this data collection will allow for better targeted campaigning to reduce wage inequality across the country."
Latest News from
Welsh Government must revise funding to save our museums10/08/2020 12:25:00
The Senedd’s Culture, Welsh Language and Communications Committee has now published its report on the impact of the COVID-19 outbreak on heritage, museums and archives in Wales.
Welsh Government must act to ensure national treasures remain accessible to all, says FDA27/07/2020 10:20:00
The FDA has called on the Welsh Government to invest whatever is needed to protect Welsh national treasures and to ensure everyone in Wales continues to have access to their cultural history.
Parliament's restoration and renewal programme 'must not be derailed by political point scoring', says FDA17/07/2020 14:48:00
FDA National Officer for the House of Commons, Helen Kenny yesterday responded to reports that the Prime Minister has asked officials responsible for the restoration and renewal project to consider relocating Parliament to York.
'All we are asking is for the judiciary to follow government guidance'- FDA writes to the Lord Chief Justice14/07/2020 15:38:00
As the recognised union for prosecutors working in the Crown Prosecution Service (CPS), the FDA has raised serious concerns with the Lord Chief Justice over the approach taken by some judges to applications from prosecutors to appear in court remotely.
Culture sector rescue package highlights failure of current funding models07/07/2020 12:25:00
The FDA represents staff working in museums and galleries across the UK.
Departure of Sir Mark Sedwill: FDA response29/06/2020 16:20:00
FDA General Secretary Dave Penman yesterday responded to the departure of Cabinet Secretary Sir Mark Sedwill.
FDA welcomes ‘historic moment for House of Commons’ as MPs put trust in independent process24/06/2020 16:20:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the House of Commons debate on establishing the new Independent Expert Panel to deal with complaints of bullying and harassment against MPs.
Response to DFID and FCO merger17/06/2020 12:25:00
FDA National Officer Allan Sampson yesterday responded to the announcement that the Department for International Development (DFID) and the Foreign and Commonwealth Office (FCO) are to merge
HM Courts and Tribunals Service is failing to ensure safety, says FDA15/06/2020 13:15:00
As the recognised representatives of prosecutors and managers in the Crown Prosecution Service (CPS), the FDA has raised serious concerns with HM Courts and Tribunals Service (HMCTS) about its approach to reopening courts across England and Wales.